Cart
sales@molnova.com
Brivaracetam (alfaR, 4S)-Isomer
CAS No. 357336-99-3
Brivaracetam (alfaR, 4S)-Isomer( ——— )
Catalog No. M39582 CAS No. 357336-99-3
Brivaracetam (alfaR, 4S)-Isomer
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 1426 | In Stock |
|
| 25MG | Get Quote | In Stock |
|
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBrivaracetam (alfaR, 4S)-Isomer
-
NoteResearch use only, not for human use.
-
Brief DescriptionBrivaracetam (alfaR, 4S)-Isomer
-
DescriptionBrivaracetam (alfaR, 4S)-Isomer
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number357336-99-3
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PSMA I&T
PSMA I&T is a PSMA-targeting radiocompound that serves as a diagnostic agent for prostate-specific membrane antigen-targeted therapy, often coupled with radioactivity.
-
Menisdaurin
Menisdaurin is a natural product from Flueggea virosa.
-
IMS2186
IMS2186 is a reagent with activity of antichoroidal neovascularization (CNV). IMS2186 could arrest cancer cell cycle in G2/M phase, result in exerting anti-proliferation and anti-angiogenesis effects.
